# TIVDAK

NDC: 51144-003
Generic name: tisotumab vedotin
Labeler / Manufacturer: SEAGEN INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210920

FDA application: BLA761208

## Active ingredients

- TISOTUMAB VEDOTIN: 40 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51144-003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51144-003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9fe3f32-4219-466e-acb9-3f609b4f4df1